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Abstract 
The Agatha Breast Unit at Mater Dei 
Hospital, Malta performed 340 wide local excisions 
for cancer in 2013-4. Further surgery for close or 
involved surgical margins was performed in 45 
cases (13%), of these 26 (58%) underwent cavity 
excision and 19 (42%) underwent mastectomy. 
Residual tumour was found in 9 (35%) in the cavity 
excision group and 13 (68%) of the mastectomy 
group. The authors discuss how their unit follows 
the recommendations of the “Toolbox to reduce 
lumpectomy reoperations and improve cosmetic 
outcome in breast cancer patients of the American 
Society of Breast Surgeons Consensus Conference” 
and what can be done to reduce re-operation rates 
further. 
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Introduction and Aim 
Breast cancer is the most prevalent cancer in 
European women and the incidence is increasing 
but mortality rates are decreasing. In our unit 70% 
of patients undergo breast conservation therapy 
(BCT) aiming to control local disease and achieve 
cure with the best possible cosmetic result and 
allowing the patient to have a good quality of life.1 
An inadequate surgical margin may lead to local 
recurrence but re-excision to achieve an optimum 
margin leads to a worse cosmetic outcome and 
other problems. 
The aim of this study is to assess re-operation 
rates in breast cancer patients after wide local 
excision in our unit. This was done by reviewing 
the histology results of the original surgery and 
those of the subsequent cavity excision or 
mastectomy, studying residual tumour rates in the 
two types of re-operation.   
 
Methods 
Data Collection and Sampling. 
Data was collected from theatre lists of the 
two local breast surgeons for all wide local excision 
operations performed for cancer during 2013 and 
2014 at the Agatha Breast Unit at Mater Dei 
hospital, Malta. Histology reports were accessed 
from the hospital database and patient records were 
reviewed as necessary.  
 
Results 
A total of 340 wide local excisions were 
performed in 2013 and 2014. Further surgery was 
performed in 45 (13%) to achieve clear margins. Of 
these, cavity excision was performed in 26 patients 
(58%) and mastectomy in 19 patients (42%). 
Residual tumour was found at the second operation 
in 9 patients (35%) in the cavity excision group and 
in 13 (68%) in the mastectomy group (49% 
overall). This is outlined in table 1.  
The collected data was analysed statistically 
using IBM SPSS to check if there is a statistically 
significant difference in the size of original tumour 
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between patients undergoing cavity excision or 
mastectomy at subsequent surgery. 
 
Table 1: Wide local excisions and re-operations for 
breast cancer in 2013 and 2014 
 
Out of the patients who underwent cavity 
excisions, 23(88.5%) had invasive carcinoma at 
original histology while 3(11.5%) had both invasive 
carcinoma and DCIS. The patients who 
subsequently had a mastectomy had 12 (63.2%) 
who had invasive tumour orginally and 7 (36.8%) 
who had both invasive carcinoma and DCIS. When 
comparing the two groups, more patients who 
eventually had mastectomy had both invasive 
tumour and DCIS in the original histology 
(P=0.009), while more patient who had a cavity 
excision had only invasive tumour initially 
(p=0.02). 
The average size of the initial tumour was 
23mm (range 8-48) in those who subsequently 
underwent cavity excision and 33mm (range 6-75) 
in those who underwent mastectomy.  The 
difference in size was statistically significant, 
p=0.03 using a T-test.  
Out of 26 cavity excisions, 9 (35%) had 
residual tumour on histological assessment and out 
of 19 mastectomies 13 (68%) had residual disease. 
The mastectomy group had a statistically significant 
higher rate of residual cancer when compared to the 
cavity excision group (p=0.025, using a Pearson 
Chi-Square test).  
In the mastectomy group 5 patients (26%) had 
an initial tumour which was larger than 40mm on 
histology of the original operation, 7 patients (37%) 
had multifocal disease, 2 (11%) had chemotherapy 
between the initial and delayed surgery, 4 (21%) 
had extensive DCIS and one (5%) had previously 
undergone risk reduction bilateral subcutaneous 
mastectomy and immediate reconstruction for high-
grade DCIS.  
 
 
Figure 1: Re-operations for incomplete excision of breast cancer in 2013 and 2014 
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The average length of time in between 
surgeries was 58.61 days for the mastectomy group 
(range 27-209 days) and 62.22 days for the cavity 
excision group, excluding those patients who had 
chemotherapy in between the surgeries (range 22-
205 days).  The total average time between 
surgeries was 60.41 days. This implies that patients 
undergoing re-operation undergo substantial delays 
to start adjuvant treatment. 
 
Discussion 
Surgery is the mainstay treatment of breast 
cancer with breast conserving therapy now being 
the preferred option. Breast conserving therapy 
(BCT) includes breast conserving surgery (BCS) 
followed by moderate dose radiation therapy to 
eradicate residual microscopic disease.  An 
overview of completed trials and 9 prospective 
randomised clinical trials comparing BCT with 
mastectomy showed equivalent survival rates 
between the two approaches.2-11 The main aim of 
BCT is to provide a more cosmetically acceptable 
breast associated with a low rate of recurrence in 
the treated breast.  12 However in breast conserving 
surgery an adequate negative margin around the 
tumour is required to achieve full clearance. A 
positive margin may lead to further surgery which 
may either involve further local treatment (cavity 
excision) or mastectomy at a later stage.13 
Reoperation may have consequences such as 
delaying adjuvant treatments, and increased rates of 
local and distal recurrence.14-16 Other 
consequences may include poorer cosmetic 
outcome and emotional distress which may delay 
recovery, with the resulting socioeconomic impact 
due to inability or delay in resuming work and also 
additional financial burden on the healthcare 
system.17  
The latest NCCN guidelines state that for 
DCIS a margin status of less than 1 mm is 
considered inadequate, 10mm is considered a good 
margin but may affect cosmetic outcome. If the 
margin is between 1-10mm, the wider the margin 
the lower the local recurrence rate.  For margins of 
less than 1 mm between the fibroglandular 
boundary (i.e. chest wall or skin) re-excision is not 
mandatory. However, this may require higher 
radiotherapy doses postoperatively.18 In infiltrating 
carcinoma, a negative margin is considered as ‘no 
ink on tumour’ as described by the 2014 Society of 
Surgical Oncology – American Society for 
Radiation Oncology Consensus Guidelines on 
Margins.19 Positive margin requires re excision in 
the form of further breast conserving therapy if 
appropriate or mastectomy, because there is 
increased risk of ipsilateral breast tumour local 
recurrence. There is still controversy regarding the 
appropriate margin however most surgeons take this 
to be 2mm. 20  
It has been shown that 25% of local 
recurrences are associated with survival reduction at 
20 years.2 Loco-regional recurrence is a product of 
sufficient tumour volume reduction (a clear margin 
is a surrogate marker), tumour biology, 
radiotherapy and systemic treatment. There are no 
prospective randomized trials that directly address 
the influence of margin width on local recurrence or 
define an optimal marginal width. What constitutes 
an acceptable margin must be individualized within 
the context of the tumour size, biology, stage and 
planned treatments.1  
Reoperation rates after breast conserving 
surgery can be high, with rates of 17% to 68% 
quoted in various studies.21-28 Women having an 
in situ component were more likely to have at least 
one reoperation.29 The results from our unit 
compare well with these figures.  
Our unit strives to decrease re-operation rates 
by following the recommendations of the 
Consensus Conference Toolbox to reduce 
lumpectomy reoperations and improve cosmetic 
outcome in Breast Cancer Patients of the American 
Society of Breast Surgeons. 30   
Pre-operative imaging is done with full-field 
digital mammography and ultrasound as needed. 
MRI is used for patients with lobular carcinoma. 
All patients undergo breast biopsy before surgery 
and they are discussed at a multi-disciplinary team 
meeting that includes surgeons, radiologists, 
pathologists and oncologists. Non-palpable breast 
lesions are localized, and multiple wires or seeds 
are used for large lesions, multifocal tumours and 
extensive DCIS. Oncoplastic surgical techniques 
allow resection of larger amounts of breast tissue 
and this may include contralateral breast 
symmetrization surgery. All operative specimens 
are oriented by placement of sutures at surgery, a 
short suture is used to label the superior margin, a 
medium suture for the medial margin and a long 
suture for the lateral margin. All specimens are 
weighed to facilitate reconstruction when necessary. 
When the lesion is not palpable the specimen is 
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labelled with metal clips (LigaclipsTM) and 
radiographed. This will document that the lesion 
has been removed and assessment of the margin. A 
cavity shave is performed if the margin is “close”. 
We do not perform routine cavity shaves of side 
walls or intraoperative pathology assessment of 
lumpectomy margins. 
Not all patients who have positive or close 
margins in the first operation are found to have 
residual tumour at the second operations. Rates of 
18.8% to 33% have been quoted, while we report 
residual tumour in 49% of re-operated 
patients.20,22 Residual disease has been associated 
with multifocality but no other associated factors 
have been identified.22  
Patients treated with repeat BCS had similar 
outcomes to those who underwent mastectomy. 
This was shown by a retrospective review and a 
prospective study which both showed no significant 
difference in survival rate following both 
management options i.e. mastectomy versus repeat 
BCS.31, 32   
Our study compared two groups of women 
who underwent further excision after their initial 
breast-conserving surgery, for close or involved 
margins with tumour or in-situ disease. Some 
underwent a cavity excision while others had a 
mastectomy as their second surgery.  Patients 
undergoing cavity excision were found to have 
residual tumour in 35% of cases compared to 68% 
of patients with residual tumour in the mastectomy 
group (p=0.025).  This implies that mastectomy is 
more likely to result in a positive result and 
therefore more likely to result in complete 
histological excision than breast conserving cavity 
excision. It may also imply that in repeat cavity 
excision the surgeon might not manage to excise 
residual disease as this may be difficult to localize. 
There was also a significant difference in the initial 
tumour size, as those patients who underwent a 
mastectomy as a second procedure had larger 
average initial tumour size (p=0.03). This implies 
that a larger initial tumour size may influence the 
decision to perform a mastectomy as a second 
surgery if this is required.  
Limitations of this study include a small 
sample size of re-operated patients and the 
retrospective nature of the study.  
Lateral margin cavity shave during the initial 
breast conserving surgery has been shown to 
decrease the re-operation rates for margin clearance 
but the excised volume is increased and this may 
unnecessarily compromise cosmetic 
outcome.21,29,33-35  Intra-operative margin 
assessment using frozen section reduces re-excision 
rates but this is not widely available.36 A 
commercially available RF spectroscopy probe 
(MarginProbe) has been shown to decrease re-
operation rates.37 Our unit proposes to study these 
three techniques in an effort to further improve our 
re-operation rate. 
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